Exane Derivatives’s NovoCure NVCR Stock Holding History

Exane Derivatives’s Portfolio NVCR Stock Details NVCR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$208	Sell
2022 Q1	$65.4K	Sell
2021 Q4	$71.3K	Sell
2021 Q3	$143K	Sell
2021 Q2	$271K	Sell
2021 Q1	$250K	Sell
2020 Q4	$469K	Buy